Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+2.96M
-
Total reported value, excl. options
-
$43.1M
-
Value change
-
+$8.05M
-
Put/Call ratio
-
1.29
-
Number of buys
-
47
-
Number of sells
-
-29
-
Price
-
$3.21
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2022
94 filings reported holding HUMA - Humacyte, Inc. - COM as of Q2 2022.
Humacyte, Inc. - COM (HUMA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.67M shares), BlackRock Inc. (2.4M shares), York Capital Management Global Advisors, LLC (2.29M shares), UBS OCONNOR LLC (1.1M shares), GEODE CAPITAL MANAGEMENT, LLC (778K shares), Prescott General Partners LLC (568K shares), STATE STREET CORP (418K shares), MILLENNIUM MANAGEMENT LLC (399K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (331K shares), and LPL Financial LLC (298K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.